Project Details
Description
A Randomized, Placebo-Controlled, Blind-Start, Single-Crossover Phase 3 Study to Assess the Efficacy and Safety of UX003 rhGUS Enzyme Replacement Therapy in Patients with MPS 7
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/17 → 11/1/17 |
Funding
- ULTRAGENYX PHARMACEUTICAL INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.